Acorda Therapeutics, Inc.

NASDAQ: ACOR
$0.85
+$0.05 (+6.2%)
Closing price April 2, 2020
Thursday's top analyst upgrades, downgrades and initiations included BankUnited, Caterpillar, Costco, eBay, Ford, Kellogg, Lyft, Microsoft and Oshkosh.
Lee Jackson
The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and Ferrari.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo and Roku.
Jon C. Ogg
Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User Fee Act goal date for its review of the New Drug Application of...
Chris Lange
The top analyst upgrades, downgrades and other research calls from Friday include Alarm.com, Biogen, Blue Apron, Cisco, Lowe's, Pandora Media and Waste Management.
Jon C. Ogg
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Thursday include Cisco Systems, Dollar General, NetApp, Pandora Media, Procter & Gamble and Target.
Jon C. Ogg
Acorda Therapeutics saw its shares drop sharply following an announcement that it had paused new enrollment in a long-term safety study. In a sense, Acorda has halted this trial.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday include Equifax, Mallinckrodt, Nabors, Qualcomm, Salesforce and Snap.
Jon C. Ogg
Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from the FDA in regards to its New Drug Application for Inbrija.
Chris Lange
The top analyst upgrades, downgrades and initiations seen on Monday include AIG, Boeing, GameStop, Gilead Sciences, Starbucks, CIGNA, Ciena and Ferrari.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Wednesday include BBVA, Fossil, Procter & Gamble, T-Mobile, Under Armour and Universal Display.
Jon C. Ogg
Shares of Acorda Therapeutics saw a hand gain in early trading on Thursday after the company reported results from its late-stage Parkinson’s trial.
Chris Lange
Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.
Lee Jackson
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is watching its shares slide on Monday after the company gave an update on a recent clinical study. Essentially, the company announced that its Milestone...
Chris Lange